In the past two decades many attempts have been made t o relate surface and interfacial parameters with the blood compatibility of polymeric surfaces. It is however doubtful if by a single parameter the behaviour of blood on a surface can be predicted. Two major aspects of blood compatibility --the prevention of platelet adhesion and the deactivation of the intrinsic coagulation system are determined by the measure and nature of competitive blood protein adsorption on the foreign surface. The adhesion of blood platelets is promoted by adsorbed fibrinogen and gamma globulin, while adsorbed albumin inhibits platelct adhesion. Heparinised surfaces d o not adsorb fibrin and consequently no adhesion of platelets takes place. Othcr surfaces with low platelct adhesion are the hydrogels, certain block copolyetherurethanes, polyelectrolyte complexes and biolised proteins. Heparinised surfaces of the cationically bonded type inhibit the intrinsic coagulation as well, however this may be due to unstable coatings and heparin leakage. In the authors laboratory a synthetic heparinoid was prepared with the structure
INTRODUCTION
The clinical use of blood contacting devices and prosthcses is of major importance today in cardiovascular surgery and other fields of medicine. Heart valve ~ and blood vesscl prostheses, balloon pumps, and catheters are being implanted in daily surgical practice t o restore or diagnose carhovascular function. Artificial organs are routinely employed in blood dlalysis (artificial kidney), in blood detoxification by adsorptive haemopcrfusion and in oxygenation (membrane oxygenators and heart-lung devices). Considerable effort and capital is invested in Europe and the USA in the dcvclopment and experimental evaluation of an implantable artificial heart system. These devices are generally constructed from polymeric materials and when in use a blood-polymer contact is present. TIUS contact will cause a reaction in the recirculating blood, w h c h , depending on the materials choice, the design parameters, the flow or the addition of anticoagulants may lead t o protein deposition, adhesion and destruction of red blood cells (haemolysis), platelet (thrombocyte) adhesion and aggregation and blood coagulation leading to the formation of a haemostatic plug (thrombus) (Fig. 1) . The occurrence of thromboembolism in cardtovascular surgery continues t o be a problem, notwithstanding routine treatment with anticoagulants. For these reasons the search for blood compatible nonthrombogenic materials has been an important research objective over the last two For a perception of the routes along which 
Protein adsorption
The very first event on blood-polymer surface contact is a rapid adsorption of plasma proteins from the blood onto the material surface. Upon adsorption of plasma proteins the material surface will be altered and the subsequent events will be determined by the modified surface. The relation between the character of the polymeric surface and the rate of protein adsorption and the composition and thickness of the adsorbed protein layer is today largely unknown, notwithstanding the numerous research reports and publications in this area.4-6 Protein adsorption generally follows a Langmuir adsorption and hydrophobic surfaces interact more strongly with proteins9 and adsorb more protein than hydrophilic surface^.^ Generally hydrophobic surfaces adsorb proteins irreversibly.1° There are strong indcations that preferential adsorption of one type of blood protein over another may play an important role in the sequential events -platelet adhesion and coagulation. Many polymers adsorb fibrinogen rapidly," which in its turn can promote the adhesion of blood platelets.' 2-14 For certain block copolyetherurethanes it was reported that a high and specific albumin adsorption determines its high blood compatibility.'
Heparin coated surfaces do not adsorb fibrinogen and platelets do not adhere on these surfaces.16-18 Although a number of authors report on competitive adsorption studies with radiolabelled protein^,^^,^^ more work is necessary t o obtain necessary insight in the first phase of the blood coagulation. In the authors laboratory a study indicated that one should be extremely careful in the selection of the radiolabelled proteins.21 Several procedures for labelling proteins resulted in unstable labels, but even stable 99n1Tc and 1251 labelled sei-um albumin showed preferential adsorption over unlabelled albumin. For better understanding of blood coagulation the work on competitive adsorption of blood proteins should continue but with biologically produced radiolabelled starting materials where the danger of preferential adsorption is niinimise d. Fig. 2 gives a schematic sequence of events following the protein adsorption, which are described below in inore detail.
Exposure of blood to a foreikm material 2. Adsorption of proteins from the blood onto the foreign material.
3. Adhesion of platelets to the adsorbed protein layer. 4. Release of ADP and othcr platelet constitutcnts. ]:ormation o f a platelet aggregate. 5. The coagulation process is started on the surface of the aggregating platelets. Formation of an insoluble fibrin network. 6. Individual platelets lose their intcgrity and fuse with each other.
1,'ibrin strands with entrapped cells from the blood form a red thrombus.
Interaction of a foreign material with blood.
4a Formation of a white thrombus by aggrcgating platelets. l a The coagulation process is started by activation of factor XI1 on I b Thrombin is formed during the coagulation process, resulting in thc foreign surface.
platelet asregation.
Platelet adhesion and aggregation22 ,23
The adhesion of thrombocytes on a polymer surface is presumably caused by the formation of an enzyme-substrate complex between the enzyme glycosyl transferase on the thrombocyte's surface and heterosaccharides of the adsorbed glycoproteins fibrinogen and gamma g l~b u l i n .~.~~ Sugar nucleotides can then be transferred from the platelet t o the protein. This is not possible with albumin as it is a pure protein and saccharide chains are not present here. This adhesion mechanism is similar t o that suggested for the interaction of platelets with collagen in case of damage to the wall of a blood-vesseLZ After adhesion the platelets show tentacle like protrusions, the pseudopods; they then contract and undergo the release reaction, whereby adenosine diphosphate (ADP), serotonine and other substances are freed. ADP causes more platelets to stick t o those already adhering. Thus platelet aggregation takes place as an autocatalytic process. In a still later phase the platelet aggregates undergo 'viscous metamorphosis', fusion into a homogeneous w h t e thrombus. When at the thrombocyte surface enzymatic coagulation factors are activated the result will be a red thrombus, built up of fibrin fibres, platelets, red cells and other blood components. When anticoagulants are present fibrin is not forined and only a white thrombus forms as has been observed in arterial-venous shunts under conditions of h e p a r i n i~a t i o n .~~
Intrinsic coagulation
Intrinsic coagulation is a complicated process of a number of reactions occurring mainly between soluble proteins in blood or plasma. The final step is the conversion of soluble fibrinogen into insoluble fibrin fibres. The proteins ale called coagulation factors. Fig. 3 is based on recent data28 and shows the sequential activation of the factors in a 'cascade mechanism'. The coagulation is set in motion by activation of factor XI1, the Hageman factor, through adsorption on a foreign surface. The activated factor XI1 (XIla) activates factor XI on the surface proteolytically. Calcium ions play an important part in the activation of a number of factors. The coagulation process and the adhesion and aggregation of platelets proceed independently although in the later phases of platelet aggregation interaction with the blood coagulation may occur.
The influence of flow conditions on platelet adhesion and intrinsic coagulation are not dealt with here, but are described elsewhere. 8a
Anticoagulation
T o prevent coagulation direct or indirect anticoagulants are used. The latter type prevents the biosynthesis of some coagulation factors. An example is 4-hydroxy coumarin. A direct anticoagulant is lieparin29.30 (see Fig. 4 ), a niuco polysaccharide carrying sulphate, sulphamate and carboxylate groups. Depending on its natural source its & t , may vary from 8-20,000. Its activity is based on the catalytic activation by heparin of antithrombin 111, the heparin cofactor, which is present in the blood. Activated AT 111 forms complexes with thrombin31132 and also with the activated factors VIIa,33 IXa,34 Xa35 and XIa,36 thus inhibiting coagulation and fibrin formation. Heparin does not occur freely in the blood, but it is present in the blood-vessel w a l l~.~~-j ' Its half-life in the body is around 1.5 hours.40 The molecular basis for the anticoagulant activity is not very well understood. Other naturally occurring sulphated polysaccharides are considerably less or not at all a~t i v e .~l -~~ However the presence and level of sulphamate g r o~p s~~-~~ is of essence for its activity, which also depends on the molecular46 weight. 
BLOOD COMPATIBLE MATERIALS
For the correlation with blood-surface interaction phenomena a number of parameters were suggested -surface and interfacial parameters, surface charge and ( potential, conductivity and domain structure. 
The structure of heparin.
Surface and interfacial parameters4'
A first attempt t o relate surface properties with bood compatibility dates from 1930.48 It was stated that clotting time was inversely proportional t o the wettability of a surface. It is however generally incorrect t o state that a hydrophobic surface is less thronibogenic than a hydrophilic one. Much later surface free energy or surface tension, defined as y = F-FYA ( F = free energy of the bulk, F ' = free energy of the surface, A = surface area), was considered as a criterion for blood c o t i i p a t i b i l i~y .~~.~~ It is more logical t o consider the interface of the polymer with blood, and the interfacial free energy defined as y s L = ys -yslLl + y~ -y~l s l has been considered as a paraiii~ter.~' (ys and yL are the surface tensions of the solid and liquid respectively and ysl and yLls1 express the effect of one phase upon another).
When a drop of liquid is placed on a surface the equilibrium spreading of the liquid is given by the Young-Dupre relation:
(0 = contact angle, the interfacial tensions are given by ysv (solid vapour), ysL (solid-liquid) and yLv (liquid vapour).
From contact angle nieasuremcns the surface free energies of polymers were c a l c~l a t e d .~~ These data were used later to generate data for the interfacial t e~i s i o n s ,~~,~~ but some questionable assumptions make these data at best rough estimations. This notwithstanding, materials with a niininial interfacial energy like hydrogels d o possess a low thromboadherence. Zisnian correlated the contact angle 0 with the yI, for the interface of the components of a homologous series of liquids on polymers.% The empirical relation cos 0 = a-by, was found.
The criticafsurjace tension yc,defincd as (a-l)/b or the value of yL for which 0 = 0 was also used as a parameter,ss though an inadequate one because of the dependence of yc on the series of liquids used.56 It must be doubted that by a single surface or interfacial parameter the behaviour o f blood on a surface can be predicted.
Surface
The blood-vessel wall has a negative ( potential of -8 t o -13 mV. s9 This surface charge may act by repulsion of negatively charged blood components such as cells and proteins. Electrets with a negative surface charge generally show better blood compatibility than the nonpolarised polynieric surface.60 Not all negatively charged Golymer surfaces are antithrombogenic; poly(styrene sulphonate) causes as much coagulation as polystyrene itself.61 Positively charged or polarised surfaces are however generally thrombogenic.62 Interesting are the complexes of polycations with an excess of polyanions, which show antithrombogenic p r~p e r t i e s .~~ olefins, polyvinylchloride, polytetrafluorethylene, cellulosics, polyesters and polyanlides are thrombogenic and application of anticoagulants is indicated. Velours, knits and porous structures are used for prolonged periods as they are designed@ to trap clots and promote i n g r o~t h~~ of fibroblastic and endothelial cells, thus producing a living surface which simulates the inner wall of the blood-vessels. Certain polyurethanes, in particular the block copolyetherurethane urea type (PEUU)66*67 are built up of polypropyleneoxide or polytetramethyleneoxide (M.W. 1025) segments with methylene (4-bis phenyl isocyanate) and aliphatic diamines such as ethylene diarnine as chain extenders. Another type, Avcothane, is a block copoly (dialkyl siloxane) urethane.68 These polymers show remarkably good blood compatibility, due to their high albumin and low fibrinogen a d~o r p t i o n .~~ The underlying reasons for t h s specific adsorption behaviour is poorly understood; the platelet adhesion is favourably affected by the types showing a minimal phase s e~a r a t i o n .~~ Their excellent flex properties and good solubility make these materials very suitable for the construction of artificial hearts.71
Hydrogels are polymers which exhibit the ability to swell in water and retain more than 20% water withm its structure.72 They provide a very low interfacial free energy system with water or blood. The best known types are poly(hydroxyethy1) methacrylate, polyacrylamide and copolymers containing poly(N-vinyl pyrrolidone-2). These types of polymer belong to thc most nonthromboardherent systems, but recent results with hydrogel grafted arterial-venous shunts indicate an increasing platelet destruction73 level with increasing water content in in vivo tests.
Polyelectrolyte complexes are hydrogel-li ke combinations of polycations and polyanions. Complexes of poly(viny1 benzyltrimethyl ammonium) chloride or poly(diallyldimethy1 ammonium) chloride with a slight excess of sodium poly (styrene sulphonate), also known as I~p l e x e s ,~~~ show good antithronibogenicity. A general problem with all hydrogel polymers is their lack of mechanical strength.
Albumin coated surfuces do not attract thrombocytes and have found succesfull clinical a p p l i~a t i o n .~~ Preliminary in vitro experiments carried out in our laboratory indicate that the activation of the intrinsic coagulation is not purely dependent on the type of preadsorbed protein but also on the nature of the material.
Riolized surfaces75 are generally composite structures of which a rough surfaced elastomeric material is treated with a solution of albumin or gelatin.76 Then a treatment with formaldehyde or glutaraldehyde is given to effect crosslinking.
Heparinized surfuces are generally obtained by ionically linking of heparin to a polymer surface by means of quaternary ammonium groups. These groups may be provided by low molecular weight detergent^^^-'^ such as tridodecyl methyl ammonium chloride (TDMAC) or benzalkonium chloridea0 as coupling agents or they may be introduced chemically into the polymer or on the surface. An example is the grafting of sjyrene by radiation to various polymers and subsequent chloromethylation and amination.*' Heparinisation with TDMAC as a coupling agent may be carried out in two ways:
(a) by a two step method where first TDMAC is brought into contact with the polymer in the presence of a swelling agent. After drying a second treatment follows with an aqueous solution of heparin to provide the final coating.
(b) a one step method in which a TDMA-heparin complex is made and direct coating takes place from a complex solution in an organic solvent.82.83
The final coating can be stabilised by crosslinking with glutaraldehyde s o l~t i o n .~~,~~ Other methods for obtaining heparinised surfaces are:
(a) mixing of heparin through the polymer before proc e s~i n g .~~,~~ These surfaces show leakage of heparin after blood contact.
(b) covalent bonding of heparin through radiation grafting88 or reactive groups ( i~o c y a n a t e ,~~ cyanuric chloride).90 Unfortunately the covalently attached heparin is much less active in preventing coagulation than the ionic complexes.
groups.18
(c) by using polymeric coupling agents with cationic linking 
Heparinoid systems93
In our laboratory a number of heparinoids have been synthesised by reaction of unsaturated polymers like poly(cis-I, 4 isoprene)94 with the specific reagent N-chlorosulphonyl i s o~y a n a t e ,~~,~~ which adds to -70% of the double bonds:
CH,-C=CH-CH, + ClO,S-N=C=O --+
I
The polymeric beta lactain sulphonyl chloride is then hydrolyzed with a 2N sodium hydroxide solution to polyelectrolyte P 1 J P
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For polyelectrolyte P the starting material was pharmaceutical grade poly(cis-1, 4 isoprene) Shell Cariflex 307), Mw : 2.4 x lo6). Polyelectrolyte P contains the same sulphamate and carboxylate groups we find in heparin, though no sulphate groups are present. The product is a watersoluble, white crystalline material with a M w of(7.5 x 1.0) x l o 5 . It is a nontoxic and nonpyrogenic9 direct anticoagulant with an in vivo activity o f 50% that o f h e p a r h g 8 In many ways its activity is similar t o that of heparin,99 with the exception o f possessing a much stronger antipolynierase activity in the polymerisation of the fibrin monomer. Its biodegradation in vivo (rabbit tests) is similar but slightly slower than heparin itself. Contrary t o heparin it will undergo gamma sterilisation without loss of activity. The presence of both sulphaniate as well as carboxylate groups is essential for the anticoagulant activity. Acid cleavage of the N--S bond to an extent of 50% as well as substitution of the carboxylate group by carbonamide resulted in loss of activity.Ioo A similar product synthesised front poIy (trans I , 4-isoprcne), Polysar 1811,Mw : 4.3 x l o 6 , gave lui almost identical product, though configurationally differcnt, with an anticoagulant activity of only half that of polyelcctrolytc P.
complexes
Coating of surfaces with polyelectrolyte P-TDMA
In analogy with the TDMk-heparin coatings, onc and two step coatings were applied to PVC surfaces, substituting thc polyelectrolyte P for heparin. Thc PVC used was of a vet-y purc grade (Breon S1 l O / l O , Mw : 56000,M11 : 28000). Solvcnt swelling of PVC is nccessary for the uptake of TDMAC. An adsorption isotherm at 20" of TDMAC on PVC in tolucne was determined (Fig. 5) . From thcsc data and from thc dctcrmination of the fraction o f t h e TDMAC on thc polymcr surface, which is capable of 36Cl-exchange, it becomes clear that most of the TDMAC is dissolved in the polynicr and only a fraction is available for ion exchangc (Tablc 2.) Little is known about the theory of polyelectrolyte adsorption on a countercharged surface. One treatment exists however, which states that the number of adsorbed units reaches a saturation value when the polyelectrolyte concentration increases.lol The number of dangling chain segmentsiM (loops and tails) greatly increases near this saturation value of the number of trains. So the ionic attachment of the adsorbed layer decreases with increasing polyelectrolyte concentration. For overall adsorption and desorption studies the polyelectrolyte P was labelled with 1251, using a modification of the Greenwood procedure.1a As in the complex formation for each ionic bond formed a chloride ion is freed, the number of adsorbed polymer segments could be determined from the exchange of Table 3 
Blood contact properties of heparinoid coatings
Coagulation cxperinients were carried out by recalcification of plasma and whole blood in coated tubes a t 37". Results are given in Table 4 and 5, which indicate the nonthrombogcnicity of the coatings. Threshold values of between 8 and 14 mg/m2 of the heparinoid seem to be required for nonthrombogenic behaviour. Platelet adhesion was measured in an ex vivo cell system based on the experimental approach of A physiological salt solution is displaced from the cells by native blood in the absence o f an air-blood interface. The blood is slowly pumped through a series of parallel flow cells of which one contains a reference material and the others the various test polymers in sheet
form. An exploded view of the cell is given in Fig. 6 . Platelet adhesion and fibrin deposition were studiedIo8 by scanning electron microscopy after glutaraldehyde fixation, rinsing and vacuum coating with a conducting layer of carbon and gold on the surfaces. Table 6 gives the results of platelet adhesion and PTT times. The heparinoid coated surfaces showed a very low platelet adhesion. In the very few platelets visible on the surface n o pseudopods could be observed. 
3.4
Heparinised surfaces do not adsorb fibrinogen. Due to the similarity with the heparinoid P coated surfaces we may assunie the absence of fibrinogen adsorption on these surfaces. This would explain the virtual absence of platelet adhesion here. The coatings show a hydrogel like structure with a relatively high water content and as such they may be nonthromboadheren t. The absence of coagulation can be connected with the anticoagulant activity of the heparinoid with the result that activation of antithrombin 111 takes place, followed by neutralisation of thrombin and other activated coagulation factors. In order t o test t h s the uptake of AT-I11 by polyelectrolyte P coated surfaces was TDMAC treated PVC powders were treated with solutions of heparinoid to obtain coztings of w h c h the composition was derived from the adsorption isotherm. The coated powders were shaken with plasma for one hour and the plasma was filtered t o determine in the filtrate the AT-111 concentraiion. Then the treated powders were washed and shaken with a thrombin solution (5U/ml). AT-I11 was determined and expressed in thonibin neutralised units. The results of the AT-111 adsorption determinations and the thrombin neutralization are given in Fig. 7 . The AT-111 adsorption is proportional to the surface concentration of the polyelectrolyte P, as is the subsequent neutralisation of thrombin. Minimum levels of around 10 nig/in2 are required for nonthrombogenici t y . 
CONCLUSIONS AND FUTURE PERSPECTIVES
A number of approaches have led t o diverse blood compatible surfaces. What is lacking is a better fundamental insight in the processes involved in the interaction of the material and biological medium. A phenomenon such as the preferential adsorption of albumin on certain copolyether urethanes should be studied extensively, both from the materials as from the haeniatological and biochemical angles to obtain insight in the reasons for selective protein adsorption, which may offer the key t o a final solution t o the blood compatibility problem. The minimal interfacial free energy concept, which has led to nonthroniboadlierent hydrogcls, deserves further scrutiny, but need broader investigations in view of the recent discovery of higher platelet destruction with increasing gel water content. The field of polymeric heparinoids is, as a part of the field of polynieric drugs an open research area where advantages exist over routinely used anticoagulants such as heparin. The slow release of anticoagulants may offer improved opportunities for treatment. The effects of flow on blood compatibility are not extensively hiown, but research is carried out in many centres and also in the authors laboratory to evaluate the combined effects of shear and materials contact on blood compatibility. 
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